Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PASG
$4.86
-2.80%
PASG
· Passage BIO, Inc.
$4.86
-0.14 (-2.80%)
At close · Sep 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$16.09M
Shares
3.22M
All earnings calls
Earnings call · FY2025 Q1
Passage BIO, Inc. (PASG) Q1 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$4.87
Net income
-$15.40M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 13, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed May 13, 2025 · complete as-filed document